Cubist Pharma - WACC Analysis

Cubist Pharma (Weighted Average Cost of Capital (WACC) Analysis)

placeholder_large_analysis.png

Banner%20-%20The%20perfect%20tool%20for%20investors%281%29.gif

Helpful Information for Cubist Pharma's Analysis

What is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Cubist Pharma's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Cubist Pharma. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Cubist Pharma before they make value investing decisions. This WACC analysis is used in Cubist Pharma's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Cubist Pharma's company valuation.

WACC Analysis Information

1. The WACC (discount rate) calculation for Cubist Pharma uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Cubist Pharma over the long term. If there are any short-term differences between the industry WACC and Cubist Pharma's WACC (discount rate), then Cubist Pharma is more likely to revert to the industry WACC (discount rate) over the long term.

2. The WACC calculation uses the higher of Cubist Pharma's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Cubist Pharma uses a significant proportion of equity capital.